| Ytd | 51.07% | |
| 1y | 52.74% |
| Open | 43.97 | Prev Close | 40.17 | Low | 39.77 | High | 43.97 | Mkt Cap | 503.77M |
| Vol | 0.00 | Avg Vol | 327.50K | EPS | 0.42 | P/E | 95.64 | Forward P/E | -56.64 |
| Beta | 0.86 | Short Ratio | 3.33 | Inst. Own | 65.62% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 01-03 | Earning | 05-13 | 50-d Avg | 41.98 | 200-d Avg | 33.55 | 1yr Est | 89.00 |
XOMA News
EMERYVILLE, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation today announced that
Acquisition adds seven commercial products including VABYSMO® (faricimab-svoa), OJEMDA™ (tovorafeni
EMERYVILLE, Calif., June 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde an
Ligand Pharmaceuticals Incorporated will acquire XOMA Royalty Corporation for $39.00 per share in ca
BALA CYNWYD, Pa. , May 05, 2026 (GLOBE NEWSWIRE) -- Brodsky and Smith reminds investors of the follo
Top analysts downgraded APPN and XOMA stocks. Visit analyst ratings page to see other views. Should
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,
XOMA Royalty (XOMA) witnessed a jump in share price last session on above-average trading volume. Th
NEW YORK, April 27, 2026 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law v
Ligand Pharmaceuticals Inc. (NASDAQ:LGND) on Monday said it is expanding its royalty portfolio throu
Ligand to acquire XOMA Royalty for $739 million, raising 2026 outlook as analysts maintain Buy ratin
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
U.S. stocks were lower, Dow Jones fell 0.1% on Monday. XOMA shares rose on Ligand's plans to acq
MILWAUKEE, April 27, 2026 /PRNewswire/ -- Ademi LLP is investigating XOMA (NASDAQ: XOMA) for possibl
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale
Ligand Pharmaceuticals will buy fellow biotechnology royalty aggregator XOMA Royalty for about $739
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and XOMA Royalty Corporation ("XOMA Royalty
Transaction expands Ligand's royalty portfolio to more than 200 assets and adds seven new commercial
Transaction expands Ligand's royalty portfolio to more than 200 assets and adds seven new commercial
XOMA Royalty Corporation (NASDAQ: XOMA - Get Free Report)'s stock price passed above its two hundred
Build income streams that keep working in the background so you can focus on living your life. Disco
XOMA Royalty Corporation (NASDAQ: XOMA - Get Free Report)'s stock price crossed above its two hundre
On Wednesday, 311 stocks hit new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
During Wednesday's morning trading, 254 companies set new 52-week highs.